# Teledyne Will Pay $1.1 Billion for X-Ray Detector Maker Varex Imaging > Source: > Published: 2026-08-10 15:19:15+00:00 *Teledyne is paying $18.90 a share for Varex Imaging, a Salt Lake City maker of the X-ray tubes and detectors used in CT scanners, mammography systems and industrial inspection equipment. The price tells you something plain: the hardware behind medical imaging still has value, especially as AI makes cleaner images more important.* Teledyne Technologies said on August 10, 2026 that it had agreed to buy Varex Imaging Corporation for about $1.1 billion in cash. The offer works out to $18.90 a share. The Wall Street Journal reported that Varex shares jumped about 50% to $18.60 in premarket trading after the announcement. Investors noticed. The deal has been approved unanimously by both company boards, according to the Journal, but it still needs Varex shareholder approval and the usual regulatory clearance. Teledyne expects it to close in early 2027. That is a long runway for a transaction involving a supplier of medical and industrial imaging components, and it leaves time for customers, suppliers, competitors and regulators to look closely at what Teledyne is buying. Varex is not a household name. That is the point. The company, spun out of Varian Medical Systems in 2017, makes X-ray sources, digital detectors, high-voltage connectors, image-processing software and other components that original equipment manufacturers build into scanners and inspection systems. Its products end up in CT, mammography, oncology, dental, veterinary, airport security and industrial applications. If you've had a CT scan in the last few years, there is a decent chance a Varex part was somewhere inside the machine. That's how embedded it is. ## Teledyne is buying a missing layer Robert Mehrabian, Teledyne's executive chairman, has framed the deal as complementary rather than a simple land grab. The Journal reported that he pointed to Varex's high-radiation imaging detectors for oncology as one area that adds to Teledyne's existing technology portfolio. That gap matters. Teledyne already has imaging and sensor businesses, including Teledyne DALSA, but Varex brings a deeper position in X-ray tubes, flat panel detectors and medical imaging components. Teledyne has done this before. It bought FLIR Systems in 2021 in an $8 billion cash-and-stock deal, adding thermal imaging and sensing assets to a company that already lived deep inside instrumentation, aerospace, defense, marine and industrial markets. Varex is smaller, but it follows the same habit: buy the hard, technical layer that other companies depend on but most consumers never see. Frankly, this is the less glamorous half of the AI infrastructure story. Everyone talks about GPUs and data centers. Almost nobody talks about the X-ray tube inside the scanner, or the detector panel that turns radiation into a digital image an algorithm can actually read. The hardware still counts. Varex's own recent filings show why. In its 2024 annual report, the company said its medical segment included X-ray tubes, flat panel and photon-counting detectors, high-voltage connectors, image-processing software, 3D reconstruction software and computer-aided diagnostic software. It also said its industrial products are used in cargo screening, baggage screening, nondestructive testing and inspection. This is not a narrow hospital-components business. It sits across health care, security and industrial quality control. ## The price reflects a beaten-down stock The $18.90 offer is more than a 50% premium to Varex's last close before the announcement. That sounds generous, but it also tells you how far Varex had fallen before Teledyne arrived. Varex reported $216 million in revenue for its second fiscal quarter of 2026, up 1% from a year earlier, and guided for full-year revenue of $860 million to $880 million. This was not a tiny company looking for a rescue. It was a specialized supplier trading like investors had lost patience. Varex also had real pressure on the business. In that same second-quarter release, the company reported a GAAP net loss of 19 cents per diluted share, while non-GAAP net income was 21 cents per diluted share. Cash, equivalents and marketable securities fell to $88 million from $155 million at the end of fiscal 2025, mainly because of debt refinancing and inventory built for expected demand. Those are the dry details worth keeping. They explain why an all-cash buyer could move. For Teledyne, the bet is not that X-ray components suddenly become exciting. They won't. The bet is that customers building next-generation scanners, oncology systems, cargo machines and AI-assisted imaging workflows will still need better sources and detectors - and someone who can supply them reliably. Software can only read the image it gets. The market understood it quickly. Varex holders who stayed through the weak stretch now have a cash offer on the table, and Teledyne has moved deeper into the physical layer behind medical and industrial imaging. The next question is whether regulators see a complementary fit, or a bigger concentration problem in a market where many original equipment manufacturers depend on a small group of component suppliers. **Also read:** [Meta Releases Muse Glimmer, an Open-Weight AI Model That Runs on a Laptop](https://startupfortune.com/meta-releases-muse-glimmer-an-open-weight-ai-model-that-runs-on-a-laptop/) and [Twilio Stock Just Had Its Biggest One Day Jump in Years on an AI Beat](https://startupfortune.com/twilio-stock-just-had-its-biggest-one-day-jump-in-years-on-an-ai-beat/) and [SpaceX Is Closing In On A $6 Billion Deal For Israeli AI Startup Decart](https://startupfortune.com/spacex-is-closing-in-on-a-6-billion-deal-for-israeli-ai-startup-decart/)